211 related articles for article (PubMed ID: 33686240)
1. RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling.
Li Y; Liu M; Yang S; Fuller AM; Karin Eisinger-Mathason TS; Yang S
Oncogene; 2021 Apr; 40(14):2553-2566. PubMed ID: 33686240
[TBL] [Abstract][Full Text] [Related]
2. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
Chai J; Xu S; Guo F
Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
[TBL] [Abstract][Full Text] [Related]
3. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
5. miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells.
Zhao H; Guo M; Zhao G; Ma Q; Ma B; Qiu X; Fan Q
Int J Mol Med; 2012 Nov; 30(5):1013-20. PubMed ID: 22922800
[TBL] [Abstract][Full Text] [Related]
6. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
Liu P; Yang P; Zhang Z; Liu M; Hu S
Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
[TBL] [Abstract][Full Text] [Related]
7. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
8. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
[TBL] [Abstract][Full Text] [Related]
9. Ezrin promotes invasion and migration of the MG63 osteosarcoma cell.
Zhang J; Zuo J; Lei M; Wu S; Zang X; Zhang C
Chin Med J (Engl); 2014; 127(10):1954-9. PubMed ID: 24824262
[TBL] [Abstract][Full Text] [Related]
10. LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.
Yong BC; Lu JC; Xie XB; Su Q; Tan PX; Tang QL; Wang J; Huang G; Han J; Xu HW; Shen JN
Tumour Biol; 2017 Feb; 39(2):1010428317691188. PubMed ID: 28240050
[TBL] [Abstract][Full Text] [Related]
11. Baicalein inhibits osteosarcoma cell proliferation and invasion through the miR‑183/Ezrin pathway.
Zhang J; Yang W; Zhou YB; Xiang YX; Wang LS; Hu WK; Wang WJ
Mol Med Rep; 2018 Jul; 18(1):1104-1112. PubMed ID: 29845278
[TBL] [Abstract][Full Text] [Related]
12. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway.
Li Y; Yang S; Yang S
Cells; 2022 Apr; 11(8):. PubMed ID: 35456040
[TBL] [Abstract][Full Text] [Related]
13. PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma.
Wu X; Xiang H; Cong W; Yang H; Zhang G; Wang Y; Guo Z; Shen Y; Chen B
Biochem Biophys Res Commun; 2020 Jun; 527(1):29-36. PubMed ID: 32446383
[TBL] [Abstract][Full Text] [Related]
14. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
Yao Q; Pei Y; Zhang X; Xie B
Life Sci; 2018 Jun; 203():1-11. PubMed ID: 29656060
[TBL] [Abstract][Full Text] [Related]
15. Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression.
Tsuru A; Setoguchi T; Matsunoshita Y; Nagao-Kitamoto H; Nagano S; Yokouchi M; Maeda S; Ishidou Y; Yamamoto T; Komiya S
Br J Cancer; 2015 Mar; 112(7):1232-40. PubMed ID: 25742474
[TBL] [Abstract][Full Text] [Related]
16. [Downregulation of Herg1 suppresses osteosarcoma proliferation and invasion by targeting Hippo signaling pathway].
Chen ZD; Ye WB; Zeng WR; Song C; Song W; Zhang YM; Wu J
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):338-345. PubMed ID: 31137166
[No Abstract] [Full Text] [Related]
17. RGS12 Represses Oral Cancer via the Phosphorylation and SUMOylation of PTEN.
Fu C; Yuan G; Yang ST; Zhang D; Yang S
J Dent Res; 2021 May; 100(5):522-531. PubMed ID: 33198557
[TBL] [Abstract][Full Text] [Related]
18. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
19. Tankyrase1 antisense oligodeoxynucleotides suppress the proliferation, migration and invasion through Hippo/YAP pathway in human osteosarcoma cells.
Zhou Y; Jin Q; Xiao W; Sun C
Pathol Res Pract; 2019 Jun; 215(6):152381. PubMed ID: 30926223
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
Yang C; Wu K; Wang S; Wei G
J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
